Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Tali-cel is a safe and effective therapy in patients with Relapsed/Refractory B-cell non-Hodgkin lymphoma that allows equitable access- a real-world experience from India.

Hasmukh Jain, Atharva Karulkar, Devanshi Kalra, Smrithi Ravikumar, Anand Vaibhaw, Shreshtha Shah, Afrin Firfiray, Juber Pendhari, Sameer Melinkeri, Rahul Bhargava, Neeraj Siddarthan, Dr Dinesh Bhurani, Jayachandran P.K., Esha Kaul, Prashant Mehta, Hari Menon, Bhausaheb Bagal, Kunal Goyal, Prakash Shekhawat, Pavan Kumar Boyella, Rakesh Boya, Ram Abhinav, Rayaz Ahmed, Anil Aribandi, Ashwin V Nair, Chandran Nair, Harish Palaparthi, Lingaraj Nayak, Pawan Singh, Priyanshi Pachauri, Rajat Bhattacharya, Rajiv Kumar, Ranjit Sahoo, Sharat Damodar, Vikram Mathews, Vasu Babu Goli, Abhishek Charan, Ajay Gupta, Amul Kapoor, Anupam Chakrapani, Ashish Bakshi, Bijay Prabhakaran Nair, Bilal Kazi, Debranjani Chattopadhyay, Ganesh S. Jaishetwar, Kaushal Kalra, Kishore Kumar, Lekshmon K.S, Madhav Danthala, Mallikarjun Kalashetty, Narendra Anukonda, Naveen Gupta, Nivedita Dhingra, Padmaja Lokireddy, Prasad Narayanan, Parathan Karunakaran, Prasanth Ganesan, Punit Jain, Priyanka Samal, Ramaswamy N.V., Rajan Kapoor, Shyam Aggarwal, Roy J Palatty, Sainath Bhethanabhotla, Sachin Almel, Santhosh Devadas, Sivakumaran Janakiraman, Sudeep V, Sreeraj Vasudevan, Sameer Tulpule, Suraj Chiraniya, Vijay Patil, Sumita Chaudhry, T Raja, Sunu Cyriac, Shishir Seth, Chezhian Subash, Varun Rajan, Alok Shetty, Vishwanath Sathyanarayanan, Mohammed Sadique Ansari, Nishant Tiwari, Shamil Darbar, Supriya Chawkekar, Sushmita Sahay, Manivasagam Sundharam, Ashish Saroha, Moumita Basu, Anjali Jaiswal, Yuktam Yadav, Sakshi Soni, Jayashree Thorat, Shalini Purwar, Nirali Shah, Terry Fry, Nitin Jain, Sattva Neelapu, Manju Sengar, Rahul Purwar

Blood (2025) 146 (Supplement 1): 6288.

https://doi.org/10.1182/blood-2025-6288

Published: 2025

Journal Articles

Effectiveness and Safety of Rituximab Biosimilar in Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia: Results from a Prospective, Multicentre, Real-World Registry Study

Blood (2022) 140 (Supplement 1): 12087–12088.

https://doi.org/10.1182/blood-2022-158455

Published: 2022

Journal Articles

Bortezomib Plus Dexamethasone As Induction Treatment Followed by Autologous Peripheral Blood Stem Cell Transplantation in Patients with Multiple Myeloma: A Study From India

Shyam Aggarwal, Anshul Bhalla, S.L Khatri, Anand Simar S, Manorama Bhargava, MD, R. Saran

Blood (2011) 118 (21): 4584.

https://doi.org/10.1182/blood.V118.21.4584.4584

Published: 2011

Journal Articles

Frontline Management of Myeloma with Bortezemib and Dexamethasone - Focus on Renal Failure - A Study From India

Shyam Aggarwal, Jr, MD, Mayank Jauhri, Anita Negi, Sangeeta Kohli, Sachin Minhas

Blood (2010) 116 (21): 5045.

https://doi.org/10.1182/blood.V116.21.5045.5045

Published: 2010

Journal Articles

The Experience of Hematopoietic Stem Cell Transplantation From An Emerging Centre in North India.

Satya Prakash Yadav, DCH, DNB, Manas Kalra, MD, DNB, Anupam Sachdeva, DCH, MD, Veronique Dinand, MD, PhD, Nirbhay Parashar, MBBS, Sangeeta Kohli, Dharma R Choudhary, MD, DM, Shyam Aggarwal, MD, DM

Blood (2009) 114 (22): 4317.

https://doi.org/10.1182/blood.V114.22.4317.4317

Published: 2009

Journal Articles

Patterns of Relapse and Toxicity in Patients of CML (Chronic Phase) on Imatinib Therapy.

Shyam Aggarwal, Atul Gogia, Meena Lal, Sarjana Dutt, Manorama Bhargava

Blood (2005) 106 (11): 4858.

https://doi.org/10.1182/blood.V106.11.4858.4858

Published: 2005

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Tali-cel is a safe and effective therapy in patients with Relapsed/Refractory B-cell non-Hodgkin lymphoma that allows equitable access- a real-world experience from India.

Effectiveness and Safety of Rituximab Biosimilar in Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia: Results from a Prospective, Multicentre, Real-World Registry Study

Bortezomib Plus Dexamethasone As Induction Treatment Followed by Autologous Peripheral Blood Stem Cell Transplantation in Patients with Multiple Myeloma: A Study From India

Frontline Management of Myeloma with Bortezemib and Dexamethasone - Focus on Renal Failure - A Study From India

The Experience of Hematopoietic Stem Cell Transplantation From An Emerging Centre in North India.

Patterns of Relapse and Toxicity in Patients of CML (Chronic Phase) on Imatinib Therapy.

Email alerts

ASH Publications

American Society of Hematology

Update search

Tali-cel is a safe and effective therapy in patients with Relapsed/Refractory B-cell non-Hodgkin lymphoma that allows equitable access- a real-world experience from India.

Effectiveness and Safety of Rituximab Biosimilar in Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia: Results from a Prospective, Multicentre, Real-World Registry Study

Bortezomib Plus Dexamethasone As Induction Treatment Followed by Autologous Peripheral Blood Stem Cell Transplantation in Patients with Multiple Myeloma: A Study From India

Frontline Management of Myeloma with Bortezemib and Dexamethasone - Focus on Renal Failure - A Study From India

The Experience of Hematopoietic Stem Cell Transplantation From An Emerging Centre in North India.

Patterns of Relapse and Toxicity in Patients of CML (Chronic Phase) on Imatinib Therapy.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only